Company Profile

Petri Bio LLC
Profile last edited on: 10/4/2022      CAGE: 8FJ82      UEI: C1DCLGZZ3YL1

Business Identifier: Engineering next generation of microbes to improve human, animal and plant health
Year Founded
----
First Award
2021
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1701 Purdue Avenue Apt 1
Los Angeles, CA 90025
   (310) 433-2805
   N/A
   www.petribio.com
Location: Single
Congr. District: 36
County: Los Angeles

Public Profile

Petri Bio is structured around creating novel therapeutics and health-care products inspired by the microbes all around (and inside!) all humans. The firm's development platform is designed to screen for useful compounds hidden in the genomes of beneficial microbes, and optimize them for use in treating disease. Having already achieved an early stage pipeline of three therapeutics in development, in addition to patent-pending anti-viral, Petri Bio LLC has two therapies targeting chronic diseases

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Shu Li -- Co-Founder and CEO

  Joseph Moeller Schinaman

Company News

There are no news available.